nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLC7A11—forelimb zeugopod—Parkinson's disease	0.0515	0.139	CbGeAlD
Sulfasalazine—TBXAS1—forelimb—Parkinson's disease	0.0352	0.0954	CbGeAlD
Sulfasalazine—SLC7A11—tongue—Parkinson's disease	0.0138	0.0374	CbGeAlD
Sulfasalazine—PPARG—forelimb—Parkinson's disease	0.0133	0.036	CbGeAlD
Sulfasalazine—ACAT1—forebrain—Parkinson's disease	0.00956	0.0259	CbGeAlD
Sulfasalazine—ACAT1—cardiovascular system—Parkinson's disease	0.00808	0.0219	CbGeAlD
Sulfasalazine—TBXAS1—forebrain—Parkinson's disease	0.00799	0.0216	CbGeAlD
Sulfasalazine—ACAT1—medulla oblongata—Parkinson's disease	0.00691	0.0187	CbGeAlD
Sulfasalazine—TBXAS1—cardiovascular system—Parkinson's disease	0.00676	0.0183	CbGeAlD
Sulfasalazine—ACAT1—midbrain—Parkinson's disease	0.00631	0.0171	CbGeAlD
Sulfasalazine—ACAT1—spinal cord—Parkinson's disease	0.00616	0.0167	CbGeAlD
Sulfasalazine—CHUK—cardiovascular system—Parkinson's disease	0.00602	0.0163	CbGeAlD
Sulfasalazine—SLC7A11—forebrain—Parkinson's disease	0.00586	0.0159	CbGeAlD
Sulfasalazine—PLA2G1B—cardiovascular system—Parkinson's disease	0.00566	0.0153	CbGeAlD
Sulfasalazine—IKBKB—embryo—Parkinson's disease	0.00547	0.0148	CbGeAlD
Sulfasalazine—ACAT1—head—Parkinson's disease	0.00547	0.0148	CbGeAlD
Sulfasalazine—ACAT1—nervous system—Parkinson's disease	0.00519	0.014	CbGeAlD
Sulfasalazine—ACAT1—central nervous system—Parkinson's disease	0.005	0.0135	CbGeAlD
Sulfasalazine—ACAT1—cerebellum—Parkinson's disease	0.00488	0.0132	CbGeAlD
Sulfasalazine—SLC46A1—spinal cord—Parkinson's disease	0.00459	0.0124	CbGeAlD
Sulfasalazine—TBXAS1—head—Parkinson's disease	0.00457	0.0124	CbGeAlD
Sulfasalazine—TBXAS1—nervous system—Parkinson's disease	0.00434	0.0117	CbGeAlD
Sulfasalazine—TBXAS1—central nervous system—Parkinson's disease	0.00418	0.0113	CbGeAlD
Sulfasalazine—IKBKB—cardiovascular system—Parkinson's disease	0.00409	0.0111	CbGeAlD
Sulfasalazine—SLC46A1—head—Parkinson's disease	0.00408	0.011	CbGeAlD
Sulfasalazine—CHUK—head—Parkinson's disease	0.00408	0.011	CbGeAlD
Sulfasalazine—ACAT1—brain—Parkinson's disease	0.00397	0.0107	CbGeAlD
Sulfasalazine—SLC7A11—midbrain—Parkinson's disease	0.00387	0.0105	CbGeAlD
Sulfasalazine—SLC46A1—nervous system—Parkinson's disease	0.00387	0.0105	CbGeAlD
Sulfasalazine—PLA2G1B—head—Parkinson's disease	0.00383	0.0104	CbGeAlD
Sulfasalazine—SLC7A11—spinal cord—Parkinson's disease	0.00378	0.0102	CbGeAlD
Sulfasalazine—SLC46A1—central nervous system—Parkinson's disease	0.00372	0.0101	CbGeAlD
Sulfasalazine—CHUK—cerebellum—Parkinson's disease	0.00364	0.00985	CbGeAlD
Sulfasalazine—SLC46A1—cerebellum—Parkinson's disease	0.00364	0.00985	CbGeAlD
Sulfasalazine—PLA2G1B—nervous system—Parkinson's disease	0.00363	0.00984	CbGeAlD
Sulfasalazine—PLA2G1B—central nervous system—Parkinson's disease	0.0035	0.00947	CbGeAlD
Sulfasalazine—PPARG—embryo—Parkinson's disease	0.00341	0.00922	CbGeAlD
Sulfasalazine—ALOX5—cardiovascular system—Parkinson's disease	0.00339	0.00918	CbGeAlD
Sulfasalazine—SLC7A11—head—Parkinson's disease	0.00336	0.00909	CbGeAlD
Sulfasalazine—TBXAS1—brain—Parkinson's disease	0.00332	0.00897	CbGeAlD
Sulfasalazine—SLC7A11—nervous system—Parkinson's disease	0.00318	0.00862	CbGeAlD
Sulfasalazine—SLC7A11—central nervous system—Parkinson's disease	0.00306	0.0083	CbGeAlD
Sulfasalazine—PPARG—forebrain—Parkinson's disease	0.00301	0.00815	CbGeAlD
Sulfasalazine—SLC7A11—cerebellum—Parkinson's disease	0.003	0.00811	CbGeAlD
Sulfasalazine—SLC46A1—brain—Parkinson's disease	0.00295	0.008	CbGeAlD
Sulfasalazine—CHUK—brain—Parkinson's disease	0.00295	0.008	CbGeAlD
Sulfasalazine—PLA2G1B—brain—Parkinson's disease	0.00278	0.00752	CbGeAlD
Sulfasalazine—IKBKB—head—Parkinson's disease	0.00277	0.0075	CbGeAlD
Sulfasalazine—IKBKB—nervous system—Parkinson's disease	0.00263	0.00711	CbGeAlD
Sulfasalazine—PPARG—cardiovascular system—Parkinson's disease	0.00255	0.00689	CbGeAlD
Sulfasalazine—Sulfadiazine—CYP2E1—Parkinson's disease	0.00253	0.437	CrCbGaD
Sulfasalazine—IKBKB—central nervous system—Parkinson's disease	0.00253	0.00685	CbGeAlD
Sulfasalazine—IKBKB—cerebellum—Parkinson's disease	0.00247	0.00669	CbGeAlD
Sulfasalazine—SLC7A11—brain—Parkinson's disease	0.00243	0.00659	CbGeAlD
Sulfasalazine—ALOX5—head—Parkinson's disease	0.0023	0.00622	CbGeAlD
Sulfasalazine—ALOX5—nervous system—Parkinson's disease	0.00218	0.00589	CbGeAlD
Sulfasalazine—ALOX5—central nervous system—Parkinson's disease	0.0021	0.00568	CbGeAlD
Sulfasalazine—ALOX5—cerebellum—Parkinson's disease	0.00205	0.00555	CbGeAlD
Sulfasalazine—IKBKB—brain—Parkinson's disease	0.00201	0.00544	CbGeAlD
Sulfasalazine—PTGS2—embryo—Parkinson's disease	0.00174	0.00471	CbGeAlD
Sulfasalazine—PPARG—head—Parkinson's disease	0.00172	0.00467	CbGeAlD
Sulfasalazine—Sulfaphenazole—CYP2D6—Parkinson's disease	0.0017	0.293	CrCbGaD
Sulfasalazine—ALOX5—brain—Parkinson's disease	0.00166	0.00451	CbGeAlD
Sulfasalazine—PPARG—nervous system—Parkinson's disease	0.00164	0.00443	CbGeAlD
Sulfasalazine—PTGS1—forebrain—Parkinson's disease	0.00161	0.00436	CbGeAlD
Sulfasalazine—PPARG—central nervous system—Parkinson's disease	0.00157	0.00426	CbGeAlD
Sulfasalazine—Vismodegib—ABCB1—Parkinson's disease	0.00157	0.271	CrCbGaD
Sulfasalazine—PTGS2—forebrain—Parkinson's disease	0.00154	0.00417	CbGeAlD
Sulfasalazine—ABCG2—medulla oblongata—Parkinson's disease	0.00139	0.00378	CbGeAlD
Sulfasalazine—PTGS1—cardiovascular system—Parkinson's disease	0.00136	0.00369	CbGeAlD
Sulfasalazine—PTGS2—cardiovascular system—Parkinson's disease	0.0013	0.00352	CbGeAlD
Sulfasalazine—ABCG2—midbrain—Parkinson's disease	0.00127	0.00345	CbGeAlD
Sulfasalazine—PPARG—brain—Parkinson's disease	0.00125	0.00338	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—Parkinson's disease	0.00124	0.00337	CbGeAlD
Sulfasalazine—PTGS2—medulla oblongata—Parkinson's disease	0.00111	0.00301	CbGeAlD
Sulfasalazine—PTGS1—spinal cord—Parkinson's disease	0.00104	0.00281	CbGeAlD
Sulfasalazine—PTGS2—midbrain—Parkinson's disease	0.00102	0.00275	CbGeAlD
Sulfasalazine—PTGS2—spinal cord—Parkinson's disease	0.000992	0.00268	CbGeAlD
Sulfasalazine—ABCG2—cerebellum—Parkinson's disease	0.000986	0.00267	CbGeAlD
Sulfasalazine—PTGS1—head—Parkinson's disease	0.000922	0.0025	CbGeAlD
Sulfasalazine—PTGS2—head—Parkinson's disease	0.000881	0.00239	CbGeAlD
Sulfasalazine—PTGS1—nervous system—Parkinson's disease	0.000874	0.00237	CbGeAlD
Sulfasalazine—PTGS1—central nervous system—Parkinson's disease	0.000842	0.00228	CbGeAlD
Sulfasalazine—PTGS2—nervous system—Parkinson's disease	0.000836	0.00226	CbGeAlD
Sulfasalazine—PTGS2—central nervous system—Parkinson's disease	0.000804	0.00218	CbGeAlD
Sulfasalazine—ABCG2—brain—Parkinson's disease	0.000801	0.00217	CbGeAlD
Sulfasalazine—PTGS2—cerebellum—Parkinson's disease	0.000786	0.00213	CbGeAlD
Sulfasalazine—PTGS1—brain—Parkinson's disease	0.000668	0.00181	CbGeAlD
Sulfasalazine—PTGS2—brain—Parkinson's disease	0.000639	0.00173	CbGeAlD
Sulfasalazine—CHUK—Signaling by NGF—MAPK8—Parkinson's disease	9.42e-05	0.000151	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—MAOA—Parkinson's disease	9.4e-05	0.00015	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—IL6—Parkinson's disease	9.39e-05	0.00015	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—FBP1—Parkinson's disease	9.37e-05	0.00015	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—DBH—Parkinson's disease	9.37e-05	0.00015	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GBA—Parkinson's disease	9.37e-05	0.00015	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—CASP3—Parkinson's disease	9.3e-05	0.000149	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—HMOX1—Parkinson's disease	9.29e-05	0.000149	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.28e-05	0.000149	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSTA4—Parkinson's disease	9.19e-05	0.000147	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PDYN—Parkinson's disease	9.16e-05	0.000147	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	9.15e-05	0.000146	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PENK—Parkinson's disease	9.09e-05	0.000145	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAG—Parkinson's disease	9.09e-05	0.000145	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.08e-05	0.000145	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—DDC—Parkinson's disease	9.01e-05	0.000144	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	8.97e-05	0.000144	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.96e-05	0.000143	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SNCA—Parkinson's disease	8.94e-05	0.000143	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RPL6—Parkinson's disease	8.94e-05	0.000143	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—HSPA1A—Parkinson's disease	8.93e-05	0.000143	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ABCB1—Parkinson's disease	8.92e-05	0.000143	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—IL6—Parkinson's disease	8.83e-05	0.000141	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—IL6—Parkinson's disease	8.83e-05	0.000141	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	8.83e-05	0.000141	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—DBH—Parkinson's disease	8.8e-05	0.000141	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GBA—Parkinson's disease	8.8e-05	0.000141	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—FBP1—Parkinson's disease	8.8e-05	0.000141	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—IL6—Parkinson's disease	8.75e-05	0.00014	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—IL6—Parkinson's disease	8.68e-05	0.000139	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—GSTM1—Parkinson's disease	8.66e-05	0.000139	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—DDC—Parkinson's disease	8.66e-05	0.000139	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—IL6—Parkinson's disease	8.64e-05	0.000138	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GFAP—Parkinson's disease	8.62e-05	0.000138	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.6e-05	0.000138	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—INS—Parkinson's disease	8.59e-05	0.000137	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—MAPK8—Parkinson's disease	8.54e-05	0.000137	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GRM5—Parkinson's disease	8.52e-05	0.000136	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTA4—Parkinson's disease	8.51e-05	0.000136	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—IL6—Parkinson's disease	8.5e-05	0.000136	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ADRBK1—Parkinson's disease	8.49e-05	0.000136	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	8.39e-05	0.000134	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PDYN—Parkinson's disease	8.31e-05	0.000133	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—GPX1—Parkinson's disease	8.29e-05	0.000133	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PLA2G6—Parkinson's disease	8.28e-05	0.000132	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—MAOB—Parkinson's disease	8.19e-05	0.000131	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTA4—Parkinson's disease	8.18e-05	0.000131	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	8.07e-05	0.000129	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	8.01e-05	0.000128	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ADRBK1—Parkinson's disease	7.84e-05	0.000125	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	7.82e-05	0.000125	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GFAP—Parkinson's disease	7.81e-05	0.000125	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.8e-05	0.000125	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HSPA1A—Parkinson's disease	7.78e-05	0.000125	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CYP2D6—Parkinson's disease	7.73e-05	0.000124	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GRM5—Parkinson's disease	7.73e-05	0.000124	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	7.71e-05	0.000123	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ADRBK1—Parkinson's disease	7.7e-05	0.000123	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PLA2G6—Parkinson's disease	7.66e-05	0.000123	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—MTHFR—Parkinson's disease	7.65e-05	0.000123	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CTGF—Parkinson's disease	7.59e-05	0.000122	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—MAOB—Parkinson's disease	7.59e-05	0.000121	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGF20—Parkinson's disease	7.47e-05	0.00012	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PLA2G6—Parkinson's disease	7.36e-05	0.000118	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—MAOB—Parkinson's disease	7.29e-05	0.000117	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ADORA2A—Parkinson's disease	7.24e-05	0.000116	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	7.24e-05	0.000116	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—APOE—Parkinson's disease	7.13e-05	0.000114	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CYP2E1—Parkinson's disease	7.07e-05	0.000113	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NQO1—Parkinson's disease	6.99e-05	0.000112	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.94e-05	0.000111	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ABL1—Parkinson's disease	6.92e-05	0.000111	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—TH—Parkinson's disease	6.89e-05	0.00011	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—DDC—Parkinson's disease	6.87e-05	0.00011	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RPL23A—Parkinson's disease	6.78e-05	0.000108	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RPL14—Parkinson's disease	6.78e-05	0.000108	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGF20—Parkinson's disease	6.77e-05	0.000108	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—INSR—Parkinson's disease	6.69e-05	0.000107	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CYCS—Parkinson's disease	6.62e-05	0.000106	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ADORA2A—Parkinson's disease	6.57e-05	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HGF—Parkinson's disease	6.51e-05	0.000104	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTA4—Parkinson's disease	6.49e-05	0.000104	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—DDC—Parkinson's disease	6.46e-05	0.000103	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	6.41e-05	0.000103	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RPS8—Parkinson's disease	6.32e-05	0.000101	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGF20—Parkinson's disease	6.32e-05	0.000101	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGB—Parkinson's disease	6.32e-05	0.000101	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HTR1A—Parkinson's disease	6.29e-05	0.000101	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ABL1—Parkinson's disease	6.28e-05	0.0001	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TAC1—Parkinson's disease	6.19e-05	9.91e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL6—Parkinson's disease	6.12e-05	9.8e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	6.1e-05	9.77e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTA4—Parkinson's disease	6.1e-05	9.76e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CYP2D6—Parkinson's disease	6.09e-05	9.75e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—INS—Parkinson's disease	6.09e-05	9.74e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—DRD1—Parkinson's disease	6.07e-05	9.72e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—INSR—Parkinson's disease	6.06e-05	9.7e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—IL6—Parkinson's disease	6.02e-05	9.63e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CTGF—Parkinson's disease	5.98e-05	9.57e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HGF—Parkinson's disease	5.9e-05	9.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—DRD3—Parkinson's disease	5.88e-05	9.41e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—COMT—Parkinson's disease	5.86e-05	9.38e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PLA2G6—Parkinson's disease	5.85e-05	9.36e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GSTP1—Parkinson's disease	5.83e-05	9.34e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—MAOA—Parkinson's disease	5.82e-05	9.32e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MAOB—Parkinson's disease	5.79e-05	9.26e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—HMOX1—Parkinson's disease	5.75e-05	9.21e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGB—Parkinson's disease	5.73e-05	9.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HTR1A—Parkinson's disease	5.7e-05	9.12e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CYP2D6—Parkinson's disease	5.64e-05	9.03e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TAC1—Parkinson's disease	5.61e-05	8.99e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CYP2E1—Parkinson's disease	5.57e-05	8.92e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL6—Parkinson's disease	5.55e-05	8.88e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CTGF—Parkinson's disease	5.53e-05	8.86e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ABCB1—Parkinson's disease	5.52e-05	8.84e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NQO1—Parkinson's disease	5.51e-05	8.82e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.51e-05	8.82e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—DRD1—Parkinson's disease	5.5e-05	8.81e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	5.49e-05	8.79e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ADRBK1—Parkinson's disease	5.49e-05	8.79e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—IL6—Parkinson's disease	5.46e-05	8.73e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MAOB—Parkinson's disease	5.44e-05	8.7e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—TH—Parkinson's disease	5.43e-05	8.69e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CYP2D6—Parkinson's disease	5.42e-05	8.67e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MAPK8—Parkinson's disease	5.37e-05	8.6e-05	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—IL6—Parkinson's disease	5.37e-05	8.59e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GSTM1—Parkinson's disease	5.36e-05	8.58e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—DRD3—Parkinson's disease	5.33e-05	8.53e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CTGF—Parkinson's disease	5.32e-05	8.51e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—DRD2—Parkinson's disease	5.32e-05	8.51e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HTR7—Parkinson's disease	5.32e-05	8.51e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MTHFR—Parkinson's disease	5.31e-05	8.5e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CYCS—Parkinson's disease	5.21e-05	8.34e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CYP2E1—Parkinson's disease	5.16e-05	8.26e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GPX1—Parkinson's disease	5.13e-05	8.22e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—Parkinson's disease	5.13e-05	8.21e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NQO1—Parkinson's disease	5.1e-05	8.16e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—TH—Parkinson's disease	5.03e-05	8.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ADRBK1—Parkinson's disease	4.98e-05	7.97e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CYP2E1—Parkinson's disease	4.95e-05	7.93e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—APOE—Parkinson's disease	4.94e-05	7.91e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NQO1—Parkinson's disease	4.9e-05	7.84e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MAPK8—Parkinson's disease	4.87e-05	7.8e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—TH—Parkinson's disease	4.83e-05	7.73e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CYCS—Parkinson's disease	4.83e-05	7.72e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—DRD2—Parkinson's disease	4.82e-05	7.72e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HTR7—Parkinson's disease	4.82e-05	7.72e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—MTHFR—Parkinson's disease	4.74e-05	7.58e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ADRBK1—Parkinson's disease	4.64e-05	7.43e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CYCS—Parkinson's disease	4.64e-05	7.42e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—COMT—Parkinson's disease	4.62e-05	7.39e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HSPA1A—Parkinson's disease	4.61e-05	7.38e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSTP1—Parkinson's disease	4.59e-05	7.35e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—MAOA—Parkinson's disease	4.58e-05	7.34e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—HMOX1—Parkinson's disease	4.53e-05	7.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF2—Parkinson's disease	4.46e-05	7.13e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOE—Parkinson's disease	4.41e-05	7.06e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ABCB1—Parkinson's disease	4.35e-05	6.96e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1R—Parkinson's disease	4.31e-05	6.9e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP2D6—Parkinson's disease	4.3e-05	6.88e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—COMT—Parkinson's disease	4.27e-05	6.84e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EDN1—Parkinson's disease	4.26e-05	6.81e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTP1—Parkinson's disease	4.25e-05	6.81e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—MAOA—Parkinson's disease	4.24e-05	6.79e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—INS—Parkinson's disease	4.22e-05	6.76e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CTGF—Parkinson's disease	4.22e-05	6.76e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSTM1—Parkinson's disease	4.22e-05	6.76e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—HMOX1—Parkinson's disease	4.19e-05	6.71e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—IL6—Parkinson's disease	4.14e-05	6.63e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—COMT—Parkinson's disease	4.11e-05	6.57e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTP1—Parkinson's disease	4.09e-05	6.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—MAOA—Parkinson's disease	4.08e-05	6.53e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GPX1—Parkinson's disease	4.04e-05	6.47e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF2—Parkinson's disease	4.04e-05	6.47e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	4.04e-05	6.47e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—HMOX1—Parkinson's disease	4.03e-05	6.45e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ABCB1—Parkinson's disease	4.03e-05	6.44e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CTGF—Parkinson's disease	3.97e-05	6.35e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP2E1—Parkinson's disease	3.93e-05	6.3e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NGF—Parkinson's disease	3.91e-05	6.26e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTM1—Parkinson's disease	3.91e-05	6.26e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1R—Parkinson's disease	3.91e-05	6.25e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NQO1—Parkinson's disease	3.89e-05	6.23e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ABCB1—Parkinson's disease	3.87e-05	6.19e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EDN1—Parkinson's disease	3.86e-05	6.18e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TH—Parkinson's disease	3.83e-05	6.14e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—INS—Parkinson's disease	3.77e-05	6.03e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTM1—Parkinson's disease	3.76e-05	6.01e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GPX1—Parkinson's disease	3.74e-05	5.99e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—MTHFR—Parkinson's disease	3.73e-05	5.97e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HTR2A—Parkinson's disease	3.72e-05	5.96e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	3.7e-05	5.91e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYCS—Parkinson's disease	3.68e-05	5.89e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NQO1—Parkinson's disease	3.65e-05	5.85e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TH—Parkinson's disease	3.6e-05	5.76e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GPX1—Parkinson's disease	3.6e-05	5.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NGF—Parkinson's disease	3.55e-05	5.68e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOE—Parkinson's disease	3.47e-05	5.56e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOE—Parkinson's disease	3.46e-05	5.54e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYCS—Parkinson's disease	3.46e-05	5.53e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—MTHFR—Parkinson's disease	3.45e-05	5.53e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—Parkinson's disease	3.43e-05	5.49e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1B—Parkinson's disease	3.41e-05	5.46e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HTR2A—Parkinson's disease	3.38e-05	5.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—MTHFR—Parkinson's disease	3.32e-05	5.31e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—COMT—Parkinson's disease	3.26e-05	5.22e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTP1—Parkinson's disease	3.24e-05	5.19e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MAOA—Parkinson's disease	3.24e-05	5.18e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOE—Parkinson's disease	3.22e-05	5.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HMOX1—Parkinson's disease	3.2e-05	5.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTHFR—Parkinson's disease	3.15e-05	5.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOE—Parkinson's disease	3.14e-05	5.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK8—Parkinson's disease	3.13e-05	5.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—Parkinson's disease	3.11e-05	4.98e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—Parkinson's disease	3.1e-05	4.95e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOE—Parkinson's disease	3.09e-05	4.95e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCB1—Parkinson's disease	3.07e-05	4.92e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—COMT—Parkinson's disease	3.06e-05	4.9e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTP1—Parkinson's disease	3.05e-05	4.88e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MAOA—Parkinson's disease	3.04e-05	4.87e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HMOX1—Parkinson's disease	3.01e-05	4.81e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—Parkinson's disease	2.98e-05	4.77e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—INS—Parkinson's disease	2.97e-05	4.75e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—INS—Parkinson's disease	2.96e-05	4.73e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOE—Parkinson's disease	2.93e-05	4.69e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCB1—Parkinson's disease	2.88e-05	4.62e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GPX1—Parkinson's disease	2.85e-05	4.57e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK8—Parkinson's disease	2.84e-05	4.54e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—Parkinson's disease	2.8e-05	4.48e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—INS—Parkinson's disease	2.75e-05	4.4e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—INS—Parkinson's disease	2.68e-05	4.29e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GPX1—Parkinson's disease	2.68e-05	4.29e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—INS—Parkinson's disease	2.64e-05	4.22e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MTHFR—Parkinson's disease	2.63e-05	4.22e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—INS—Parkinson's disease	2.5e-05	4e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MTHFR—Parkinson's disease	2.47e-05	3.96e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOE—Parkinson's disease	2.45e-05	3.93e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOE—Parkinson's disease	2.3e-05	3.69e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—Parkinson's disease	2.2e-05	3.52e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—INS—Parkinson's disease	2.1e-05	3.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK8—Parkinson's disease	2.02e-05	3.24e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—Parkinson's disease	2e-05	3.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—Parkinson's disease	2e-05	3.2e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—INS—Parkinson's disease	1.97e-05	3.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—Parkinson's disease	1.85e-05	2.95e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK8—Parkinson's disease	1.84e-05	2.94e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—Parkinson's disease	1.81e-05	2.9e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—Parkinson's disease	1.29e-05	2.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—Parkinson's disease	1.17e-05	1.88e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—Parkinson's disease	1.09e-05	1.75e-05	CbGpPWpGaD
